DC-806

· DICE Therapeutics, Inc. (subsidiary of Eli Lilly and Company)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DC-806, covering 2025-04-04 to 2025-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male Participants [Phase 1]